Icares Medicus Financials
| 6612 Stock | TWD 116.50 1.50 1.27% |
Icares |
Understanding current and past Icares Medicus Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Icares Medicus' financial statements are interrelated, with each one affecting the others. For example, an increase in Icares Medicus' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Icares Medicus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Icares Medicus. Check Icares Medicus' Beneish M Score to see the likelihood of Icares Medicus' management manipulating its earnings.
Icares Medicus Stock Summary
Icares Medicus competes with Pegavision, StShine Optical, Bioteque, Medeon Biodesign, and Icares Medicus. ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0006612005 |
| Business Address | No 16, Shengyi |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.icaresmedicus.com |
| Phone | 886 3 657 9530 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Icares Medicus without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Icares Stock, because this is throwing your money away. Analyzing the key information contained in Icares Medicus' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Icares Medicus Key Financial Ratios
There are many critical financial ratios that Icares Medicus' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Icares Medicus reports annually and quarterly.Icares Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Icares Medicus's current stock value. Our valuation model uses many indicators to compare Icares Medicus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Icares Medicus competition to find correlations between indicators driving Icares Medicus's intrinsic value. More Info.Icares Medicus is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Icares Medicus is roughly 1.58 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Icares Medicus' earnings, one of the primary drivers of an investment's value.Icares Medicus Systematic Risk
Icares Medicus' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Icares Medicus volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Icares Medicus correlated with the market. If Beta is less than 0 Icares Medicus generally moves in the opposite direction as compared to the market. If Icares Medicus Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Icares Medicus is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Icares Medicus is generally in the same direction as the market. If Beta > 1 Icares Medicus moves generally in the same direction as, but more than the movement of the benchmark.
Icares Medicus December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Icares Medicus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Icares Medicus. We use our internally-developed statistical techniques to arrive at the intrinsic value of Icares Medicus based on widely used predictive technical indicators. In general, we focus on analyzing Icares Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Icares Medicus's daily price indicators and compare them against related drivers.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 8.71 | |||
| Value At Risk | (3.79) | |||
| Potential Upside | 2.36 |
Additional Tools for Icares Stock Analysis
When running Icares Medicus' price analysis, check to measure Icares Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icares Medicus is operating at the current time. Most of Icares Medicus' value examination focuses on studying past and present price action to predict the probability of Icares Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icares Medicus' price. Additionally, you may evaluate how the addition of Icares Medicus to your portfolios can decrease your overall portfolio volatility.